GLOBAL IMMUNE TECHNOLOGIES INC. — Operating Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ce679fe9-2424-4e8b-9746-1c02fe6041ec/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2013 | $-2.2M | 1999-04-01 – 2013-09-30 | evidence 0001185185-13-002543 |
| FY 2012 | $-370.1k | 2012-04-01 – 2013-03-31 | evidence 0001144204-13-035667 |
| FY 2011 | $-65.1k | 2011-04-01 – 2012-03-31 | evidence 0001144204-12-063633 |
| FY 2010 | $-172.4k | 2010-04-01 – 2011-03-31 | evidence 0001144204-12-063633 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).